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ABSTRACT 
 
The primary cilium is an antenna-like sensory organelle able to 
receive extracellular signals and it is localized on the surface of 
most human cells.  
In my thesis, I investigated the connection between G-protein 
coupled receptor (GPCR) signaling and the ubiquitin 
proteasome system (UPS) pathway in the control of cilium 
stability.  I identified, at pericentriolar region, a trimeric 
complex composed by PCM1, NEK10 and PKA. I demonstrated 
that NEK10 has a crucial role for ciliogenesis. Phosphorylation 
by PKA primes NEK10 to proteasomal degradation. 
Disappearance of NEK10 promotes cilia resorption. I identified 
CHIP as the E3 ubiquitin ligase responsible of NEK10 
ubiquitination and I demonstrated that CHIP mediates the 
effects of cAMP on primary cilium stability. 
Dearangement of this control mechanism was observed in 
proliferative and genetic disorders. Collectively, the findings 
unveil a pericentriolar kinase signalosome that efficiently links 
the cAMP cascade with the ubiquitin-proteasome system, 
controlling essential aspects of ciliogenesis.  
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1 INTRODUCTION 
 
1.1 The cAMP-dependent signal transduction pathway 
 
The biological organisms are able to modify a variety of cellular 
processes to adapt themselves to multiple conditions. 
Subsequently to a change, the organism communicates to 
specific target cells through the extracellular messengers such as 
hormones, neurotransmitters and growth factors. 
The binding between a ligand and its specific receptor on the 
cell surface can lead to a different biophysical response through 
activation of specific second messengers. 
The second messengers trigger a biological response that may 
consist in the regulation of different cellular processes, as gene 
transcription, protein translation, hormone production, cellular 
differentiation and cellular division. 
The cyclic AMP (cAMP) is the most famous second messenger 
because it is involved in a wide array of biological processes
1, 2
.  
When an extracellular ligand binds a G-protein coupled 
receptors (GPCR), it starts the cAMP signaling cascade. 
The G protein-coupled family receptors (GPCRs) are a large 
family of trans-membrane proteins that transduce extracellular 
signals into the cell
3
. The binding of extracellular ligand to its 
GPCR activates the adenylyl cyclase (AC), an enzyme that 
converts the ATP in cAMP
4
. The activity of ACs is stimulated 
by the interaction with the stimulatory α subunit of the G-protein 
(Gαs). In basal conditions, Gαs forms an heterotrimeric complex 
with β and γ subunits. Subsequently to the binding of the 
extracellular messenger, the GPCRs causes the dissociation of 
heterotrimeric G-proteins, with consequent activation of ACs by 
the Gαs subunit5. 
In addition to AC, the levels of cAMP are regulated by the 
cyclic nucleotide phosphodiesterases (PDEs) and phosphatases 
(PPs).  
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Phosphodiesterases (PDEs) are involved in the regulation of the 
intracellular level of cAMP. They are part of a large superfamily 
of enzymes that hydrolize the 3′ - 5′ phosphodiester bond in the 
second messenger cAMP with the formation of 5′-AMP6. 
By reducing the levels of cAMP, PDEs regulate the duration and 
amplitude of the cyclic nucleotide signaling
7
. The subcellular 
localization of the enzymes is controlled by the N-terminal 
regulatory region
8
. The  distribution of PDEs in the cells 
generates intracellular micro domains that locally enhance the 
sensitivity and specificity of the intracellular response to the 
cAMP
9
. 
There are three distinct classes of direct effectors of the cAMP : 
cAMP-dependent protein kinase (PKA), RAP exchange proteins 
(EPACs), and cAMP gated ion channels (cNGC) (Fig.1). 
Among these effectors, the more studied is Protein kinase A 
(PKA). 
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Figure 1. Schematic diagram of cAMP synthesis and downstream 
effectors activation. When an extracellular ligand binds to and activates a 
seven-transmembrane G-protein-coupled receptor, the signal is passed 
through the heterotrimeric G protein to adenylyl cyclase. The activated 
adenylyl cyclase converts ATP into the second messenger cAMP. Principal 
effectors of cAMP are PKA, PDE and EPAC. The cyclic nucleotide 
phosphodiesterases (PDE) degrades the phosphodiester bond in the second 
messenger molecules cAMP and cGMP. RAP exchange proteins (EPACs) 
are cAMP-dependent guanine-nucleotide-exchange factors for the small 
GTPases, and are known to be important mediators of cAMP signaling. 
Finally there are cAMP gated ion channels (cNGC) that function in response 
to the binding of cyclic nucleotides as cGMP and cAMP. 
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1.2 Protein Kinase A (PKA) 
 
Protein kinase A (PKA) is a serine/threonine kinase and it is one 
of the major effector of the cAMP. Indeed, every time an 
extracellular stimulus leads to an intracellular response cAMP-
mediated, PKA is activated
10
. 
PKA is a tetrameric protein composed by two catalytic (C) and 
two regulatory(R) subunits. The whole complex makes the 
holoenzyme inactive.  
In response to the binding of a ligand to GPCRs, there is a quick 
increase of the intracellular concentration of cAMP generated by 
the ACs proteins
2
. So cAMP binds to R subunits, this binding 
causes their dissociation from the catalytic subunits (fig. 2). In 
this way, the catalytic subunits are able to phosphorylate many 
different downstream cellular substrates that include ion 
channels and a lot of transcription factors
2
.  
The biochemical and functional features of PKA holoenzyme  
are largely determined by the structure, properties and relative 
abundance of the R subunits
11
. The conserved catalytic core in 
the C-subunit  is encoded from three different genes, Cα, Cβ e 
Cγ12. The catalytic subunit is a 350-amino acid protein and the 
kinase core is localized into 40-300 residues. The smaller N-
terminal lobe is composed by β-sheets and is responsible for 
nucleotide binding
13
, whereas the larger C-terminal lobe is 
composed by α-helics and it is responsible of substrates binding 
and catalysis
11
.  
 R-subunits are encoded by four different genes (R1α, R1β, R2α 
e R2β) that confer the different biochemical and biological 
characteristics to the PKA isoforms
12
. The R-subunit 
polypeptide contains an NH2-terminal dimerization domain, an 
autophosphorylation site (that is the principal contact site for the 
C subunit) and two cAMP binding sites. Another functional site 
present on the N-terminus of the R-subunits is the 
dimerization/docking (D/D) domain that provides a docking site 
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for the A Kinase Anchoring Proteins (AKAPs) 
14
. In addition, 
the R subunits are able to form both homo-and heterodimers 
generating a large number of combinations, which further 
contribute to diversity and presumably specificity in the cAMP 
signal pathway
15
.  
The PKAs that contain either RI or RII are identified as PKA 
type I or type II and they have different sensitivities to cAMP.  
They also differ for localization and expression.  PKA type I, in 
fact, is largely cytoplasmic, whereas PKA type II is confined to 
subcellular structures and compartments. Furthermore RIα and 
RIIα are ubiquitously expressed, RIβ has been mainly abundant 
in neuronal tissues while RIIβ has the highest expression in 
neuronal, adipose,  testes and heart tissues
12, 16
. Studies 
demonstrated that ablation of the gene encoding the RIβ leads to 
deficits in hippocampal long-term depression and 
depotentiation
17, 18
 but with a compensatory increase in total 
PKA activity, suggesting a unique role for RIβ in synaptic 
plasticity
19
. A targeted disruption of the RIIα gene yields viable 
mice with no physiological abnormalities, implying that PKAI 
and/or PKAIIβ compensates for the RIIα defect20, 21. The mutant 
mices with disruption of the mouse RIIβ gene are lean and have 
elevated metabolic rates caused by increases in both basal PKA 
activity and the basal rate of lipolysis 
22, 23
. RIIβ KO mice also 
display defects in neuronal gene expression, learning and 
behavior
24, 25
. The activity of PKA is regulated by specific 
protein phosphatases. It has been demonstrated that 
phosphatases belonging to the PP1 and PP2A families are 
responsible for dephosphorylation of PKA substrates. In turn, 
PKA can control phosphatase activity by phosphorylation of 
specific PP1 inhibitors, such as I-1 and DARPP32
26
.  
PKA signaling is compartmentalized thanks to AKAPs protein. 
They are a group of several scaffold proteins that anchor the Rs 
subunits to tissues and different cellular compartments.
15
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Figure 2. PKA molecular structure and activation mechanism. 
When two molecules of cAMP bind the regulatory subunits of PKA, the 
holoenzyme is disassociates causing the activation of catalytic subunits.  
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1.3 AKAP proteins 
 
PKA is targeted to specific cellular organelles or subcellular 
locations through interaction with a family of distinct but 
functionally homologous proteins called AKAPs (A-Kinase-
Anchor-Proteins)
27-29
.  
AKAPs contain a PKA-binding motif, approximately 14 
amminoacids, that are able to bind the R subunit
7, 30
. This region 
forms an amphipathic helix in which hydrophobic residues are 
located in the interior face while charged residues align on the 
exterior surface. This helical wheel binds with high affinity the 
N-terminal docking/dimerization (D/D) domain of the PKA-R 
dimer directing it in proximity of its substrates
31
  (Fig. 3). In the 
past have been identified several AKAPs that bind both RI and 
RII subunits
32
. 
Thought their targeting domain, AKAPs protein have been 
found in various cellular organelles such as centrosomes, 
dendrites, endoplasmic reticulum, mitochondria, nuclear 
membrane, plasma membrane and vesicles. The presence of 
PKA nearby of its substrates enhances the PKA-dependent 
phosphorylation of a large number of cellular substrates. Infact 
the cells that express high levels of PKA are more responsive to 
signals caused by the intracellular increase of second messenger 
cAMP
33, 34
.  
Although AKAPs have been defined on the basis of their 
interaction with PKA, several of these molecules are able to 
bind other enzymes such as receptors, effectors, protein 
phosphatases and kinases.  In fact in the cells, AKAPs form 
macro molecular complexes, named transduceosome, where 
distinct signaling pathways converge and are attenuated or 
amplified, improving the specificity  and efficiency of biological 
responses
34-36
.  
 
 
 9 
 
 
 
J Mol Biol.The biological functions of A-kinase anchor proteins. 
Figure 3. Consensus sequence of AKAP-RII-binding domains. 
Consensus sequence derived from the alignment of the primary sequences of 
several AKAPs and the amphipathic helical wheel and the residues forming it 
are depicted as a thick line.  
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1.4 The ubiquitin proteasome system and E3 ubiquitin ligase 
CHIP 
 
In mammalian cells the post-translational modification of 
proteins is a common mechanism of cell regulation. The 
covalent modification of proteins by attachment of other protein 
is one such example. The control of this cellular mechanism is 
most important because every injury that affects this mechanism 
can lead to development of human diseases or disorders, 
including cancer. The balance between the synthesis and 
degradation of proteins is regulated by the ubiquitin-proteasome 
system (UPS).    
Ubiquitylation has a central role in several physiological 
processes and it is involved in the regulation of cell survival, 
differentiation, genetic integrity, protein quality control and 
signaling. Frequently, the substrates of ubiquitin are degradated 
through the proteasome
37
.  
This process requires the activity of three enzymes: E1 
(ubiquiting activating), E2 (ubiquitin conjugating) and E3 
(ubiquitin ligating) that act in series to catalyze ubiquitination. 
The E1 enzyme is the activating enzyme which ubiquitin is 
attached to in an ATP-dependent reaction. The E2 enzyme is the 
conjugating enzyme, which the ubiquitin is transferred to, from 
the E1. The E3 is the ubiquitin ligase, which directly or 
indirectly catalyzes the transfer of the ubiquitin to the lysine of a 
target protein, with the formation of an isopeptide bond
38
 
(Figure. 4). 
The ubiquitin substrates are not always directed to degradation 
via UPS. Infact the amount of ubiquitin tagged protein is 
balanced through the activity of deubiquitylating enzymes 
(DUBs) that reverse ubiquitylation by removing conjugated 
ubiquitin tags
39, 40
. The RING finger domain of E3 ubiquitin 
ligases contain a characteristic cysteine-rich-zinc-binding 
 11 
 
domain composed by a pattern of conserved cysteine and 
histidine residues.  
The carboxyl terminus of Hsp70-interacting protein (CHIP), 
also known as STUB1 (STIP1 homology and U-box containing 
protein1), is a member of E3 ubiquin ligase that plays an 
important role in maintenance the protein homeostasis in the 
cytoplasm
41
.  
 In literature is described that CHIP binds several members of 
the molecular chaperones Hsp70/90 family that have a central 
role in the refolding of proteins
42, 43
. Specifically, the principal 
activity of CHIP is to remove, through the ubiquitin proteasome 
system, the misfolded or damaged proteins that can lead to 
development of human cancers or other disorders
44, 45
. 
The protein CHIP was first characterized in human heart
42
. The 
important domain that allows the binding between CHIP and 
Hsp70/90 is a tetratricopeptide repeats domain (TPR) located at 
N-terminus of the protein, whereas a U-box domain at the C-
terminus of CHIP displays the ubiquitin ligase activity. 
In literature are described several ciliopathies linked to a loss 
activity of CHIP, in particular several form of ataxia such as 
spinocerebellar ataxia autosomal recessive 16 (SCAR16)
46, 47
.  
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Figure 4. Schematic representation of ubiquitin system.  
The conjugation of ubiquitin molecules to substrates requires coordinated 
action of three enzymes: the ubiquitin activating enzyme (E1), the ubiquitin 
conjugating enzyme E2 and the E3 ligase that associates the ubiquitin 
molecules to the substrates.  Once ubiquitinated, the proteins can be degraded 
by the proteasome or de-ubiquitinated by a specific DUBs enzyme.   
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1.5 Ciliogenesis  
 
The primary cilium is considered a sensory organelle able to 
receive extracellular signals and transmit them into cells. 
In mammalian cells primary cilia acts as “antennae” to sense 
signals such as growth factors, hormones, odorants and 
development morphogens
48, 49
. In the last years the focus on 
primary cilium has increased since this organelle has a critical 
role in regulating of different signaling pathways and during 
vertebrate development and tissue homeostasis
50
. 
Defects in ciliary assembly or its function can lead to several 
cilium-related human diseases called ciliopathies
51
. Ciliopathies 
are a group of genetic diseases caused by alterations of 
development, functioning and signaling of primary cilium. 
These syndromes present manifestations as polydactyly, retinal 
degeneration, mental retardation, anosmia, obesity and kidney 
cysts.  The list of ciliopathies continues to grow and at the 
present includes Bardet-Biedl Syndrome (BBS), Joubert 
Syndrome (JS), Oral-facial-digital Type I (OFD1), retinal 
degeneration, polycystic kidney disease
52
. 
Primary cilium usually forms during G1 phase of the cell cycle 
or when cells, deprived of nutrients and mitogens, exit from cell 
cycle and enter in quiescence state. 
The primary cilium grows out from centrosome, the main 
microtubule-organizing center (MTOC) in animal cells, and it is 
composed of a microtubule-based core structure called 
axoneme. The axoneme is nucleated by basal body that includes 
the mother centriole and associated pericentriolar material 
(PCM). Moreover the axoneme is surrounded by a ciliary 
membrane and it is assembled by nine parallel doublet 
microtubules which elongate from the basal body. The distal 
region of basal body, where the outer doublets begin to form, is 
called the transition zone. The ciliary pocket, an invagination of 
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the plasma membrane at the root of the cilium, is found on some 
types of mammalian cells
53
. (Fig. 5) 
 
 
 
Nature Neurology.Primary cilia in neurodevelopmental disorders 
Figure 5. Structure of primary cilium.  
 
Since the protein synthesis occurs into the cytoplasm, elongation 
of primary cilium requires the intraflagellar-transport machinery 
(IFT), two complexes that move themselves within the cilium. 
IFT complex B is responsible of anterograde transport of ciliary 
proteins from base to the tip of cilium, whereas IFT complex A 
is responsible of retrograde transport from tip to base of 
cilium
53
. In literature is described that IFT complex B is crucial 
for a correct assembly of primary cilia. In fact the lack of some 
IFT complex proteins causes short or absent cilia. By contrast, 
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IFT complex A transport back proteins to the basal body but it 
seems not be crucial for assembly of cilia
54
.  
In the cells there are a lot of positive and negative regulators that 
control the correct assembly of primary cilium. Examples of 
negative regulators are the centriolar protein Cp110 and the 
kinesin Kif24; they are able to destroy ciliary axoneme, so their 
abundance is lower during cilia assembly
55, 56
. Conversely, other 
proteins such as the ser/Thr kinase TTBK2 and MARK4 act to 
promote cilium formation. Upon serum deprivation, in fact, 
TTBK2 localizes at basal body where removes Cp110 and 
recruits IFT complexes
57
. The balance between cilia assembly or 
disassembly is regulated by also post-translational 
modifications. HEF1/Cas-L/NEDD9 is a component of focal 
adhesions that colocalizes with Aurora kinase A at the 
centrosome. Aurora A stimulates histone deacetylase 6(HDAC6) 
resulting in deacetylation of axonemal microtubules rendering 
them unstable
58
. 
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1.6 Correlation between cAMP signaling,  the UPS system and 
primary cilium 
 
In literature is extensively documented the tight correlation 
between ubiquitylation and cAMP pathway while the linkage 
that couples the cAMP cascade and primary cilium is a very 
current topic.  
Nevertheless several components of cAMP pathway, including 
G-protein coupled receptors (GPCRs), adenylate cyclases (ACs) 
and cAMP-dependent protein kinase A (PKA), conduct different 
important roles within the ciliary compartment
59
. 
In literature is documented that a pool of PKA is localized at 
centrosome, the basal structure of primary cilia
60-62
.  
In particular, PKA is a negative regulator of hedgehog (Hh) 
pathway that plays a critical role in embryonic development
63, 64
. 
In the absence of Hedgehog ligand, PKA phosphorylates Ci/Gli 
transcription factors promoting their proteolysis and the 
production of the repressor forms of Ci/Gli blocking Hedgehog 
target gene expression. In contrast, the activation of Hedgehog 
signaling increases the active forms of Ci/Gli resulting in 
Hedgehog target gene expression.  
The basal level of PKA activity in Hedgehog-responsive cells is 
precisely regulated and it is maintained at the basal body of 
cilium by interacting with A-Kinase-Anchor-Proteins 
(AKAPs)
62
. Probably, this regulation is conducted by another 
ciliary G-coupled receptor Gpr161 that, after stimulation of the 
transmembrane protein Smoothened (Smo), exits from the 
cilium maintaining inactive the PKA
65
. 
This strongly suggests the existence of a localized pool of PKA 
maintained at the base of cilium which targets Hh signaling 
during the essential steps of ciliogenesis. 
cAMP is a second messenger implicate in a wide of biological 
functions including the activity of several E3 ligases. In this 
manner, PKA modulating the activity of the principal enzymes 
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of ubiquity proteasome system, it controls the stability, the 
turnover and the biological activity of several cellular substrates. 
In neurons, PKA controls the neurite outgrowth, morphogenesis 
and improve the synaptic plasticity and memory. In response to 
an increase of intracellular levels of cAMP, the E3 ubiquitin 
ligase praja2 ubiquitinates and degrades NOGO-A, an important 
inhibitor of neurite outgrowth in mammalian brain
66
. 
Another one important correlation between cAMP cascade and 
UPS system is the regulation of the turnover of regulatory 
subunits of PKA by E3 ubiquitin  ligase praja2. When in the 
cells there is an increase of cAMP levels, praja2 promote 
ubiquitylation and subsequent proteolysis via UPS of R 
subunits,  regulate the strength and duration of PKA signal  in 
response to cAMP
67
.  
This relationship between these two systems suggest the exists 
of a circuit finely regulated in which cAMP pathway controls 
the turnover/stability of key elements of metabolic and 
proliferative pathways, but at the same time UPS regulates the 
stability of components of the cAMP cascade and the duration 
and amplitude of its signal
7
.  
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1.7 NimA related kinase 10 (Nek10) 
 
During the years, the scientific research has explained in which 
way the damages to cell cycle, checkpoint alteration and 
chromosome instability, can lead to development of cancers and 
other disorders. NIMA-related kinases (NEK) proteins are 
serine/threonine  kinase, involved in the regulation of cell cycle, 
were identified in several organisms from protists  to 
multicellular eukaryotes including  mice and humans
68, 69
. In 
literature is described that some members of this family are 
involved in ciliary functions and ciliopathies
70
. 
Statistical analysis have confirmed that this family of proteins 
coevolved with centrioles, which represent the microtubule-
organizing center and prime the assembly of basal bodies of 
cilia
71
. 
In human cells there are eleven genes that encode from NEK1 to 
NEK11 proteins. (Fig. 6)  
Nek10 gene localizes on the short arm of human chromosome 3 
(3p24.1). This gene encodes for fourteen transcripts the longest 
of which has 39 exons. The 4.25 Kbp transcript encodes a 
protein of 1172 residues with an estimate weight of 133 Kda
72
. 
Despite low overall sequence homology, the organizational 
features of NimA are broadly conserved among mammalian Nek 
kinases.  Infact all these proteins are characterized by a N-
terminal catalytic domain, except Nek10 that have its kinase 
domain in the central position. In addition to catalytic domain 
there are:  His-Arg-Asp (HRD) motif which is typical of ser/thr 
kinases regulated through phosphorylation
73
, coiled-coiled 
domains which mediate the oligomerization and PEST 
sequences which participate in ubiquitin dependent 
proteolysis
69
. 
In contrast with the conserved catalytic domain, the C-terminal 
region of NEK proteins is different in length, sequence and 
domain organization. As explained before, several NEK 
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members have important roles in cell cycle control, in particular  
NEK2 facilities spindle pole separation whereas NEK6, NEK7 
and NEK9 are important in generating the mitotic spindle
74, 75
. 
NEK1 is involved in the repair of DNA strand breaks at G1-S 
and G2-M transitions
76-78
 and NEK10 and NEK11 are involved 
in G2-M DDR checkpoint.  
Specially, NEK10 is required for the activation of extracellular 
signal-regulated kinase 1/2 (ERK1/2) signaling upon UV 
irradiation, but not in response to mitogens, such as epidermal 
growth factor. After the stimulation, NEK10 physically 
associated with Raf-1 and MEK1 in a Raf-1-dependent manner 
and the formation of this complex was necessary for Nek10-
mediated MEK1 activation. The appropriate maintenance of the 
G2/M checkpoint following UV irradiation required Nek10 
expression and ERK1/2 activation, indicating a role for Nek10 
in the cellular response to UV irradiation
68
. 
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Cell Div. Nek family of kinases in cell cycle, checkpoint control and cancer. 
Fig.6 The human NIMA-related protein kinase (NEK) family 
A schematic representation of human NEKs gene. Are indicated:  the kinase 
domains (purple), coiled-coils (green), degradation motifs (red), RCC1 
(regulator of chromatin condensation 1) domains (light blue) and armadillo 
repeats (yellow) 
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2 AIM OF THESIS 
 
The cAMP signaling pathway has been carefully studied in the 
laboratory where I practiced my PhD program. In the last years, 
our attention was focused on the relationship between 
ciliogenesis and cAMP pathway, in particular on the regulation 
of the primary cilium stability, via UPS, in response to GPCR 
signaling. By a proteomic analysis, we identified PKA as a 
component of a macromolecular complex that includes the 
pericentriolar matrix protein 1 (PCM1) and Nima-related Kinase 
10 (NEK10). PCM1 is a scaffold protein mostly localized in 
centriolar satellites and its role about the ciliogenesis is 
abundantly described
79
, whereas the involvement of NEK10 
kinase is widely unknown.  
During my PhD program, I studied the role of NEK10 in 
primary ciliogenesis. I found that NEK10 plays a major role in 
the formation of primary cilium. Activation of GPCR-cAMP 
signaling causes the disassembly of primay cilium and that this 
stimulus primes the degradation of NEK10 protein by the 
ubiquitin proteasome system through E3 ubiquitin ligase CHIP.  
Disappearance of NEK10 levels leads to cilia resorption, 
underlying the central role of cAMP-NEK10 axis in the control 
of primary cilium stability.  
Accordingly, the principal aims of my PhD thesis were the 
following: 
1. Identify NEK10 and PKA as novel components of the 
multimeric signaling complex assembled at pericentriolar region 
by PCM1.  
2. Determine the role and the mechanism of NEK10 and PKA in 
the control of ciliogenesis. 
3. Analyze the intersection between cAMP signaling and NEK10-
regulated ciliogenesis.  
 22 
 
4. Study the role of NEK10 in the ciliopathies, such as the 
autosomal recessive spinocerebellar ataxia-16 (SCAR16). 
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3 MATERIALS AND METHODS 
 
3.1 Cell lines. Human embryonic kidney cell line (HEK293) and 
primary skin fibroblasts from SCAR16 patients were cultured in 
DMEM containing 10% fetal bovine serum (FBS) supplemented 
with 2mM L-glutamine, 100 IU/ml penicillin, in an atmosphere 
of 5% CO2 at 37°C.  
 
3.2 Plasmids, siRNAs and transfection. Vectors encoding for 
NEK10-flag (wild type and mutants) and PCM1-HA were 
provided by Dr Stambolic V. and Dr Kamiya A. respectively.  
HA-Ub, CHIP-myc (wild type and K30A mutant), HSP70-V5, 
were provided by Dr Carlomagno F. and epitope Myc tagged 
RIIβ vectors were kindley provided by Dr Ginsberg SH. NEK10 
phosphorylation mutants (T223A and T812A) were generated 
by PCR using specific oligonucleotides. siRNAs targeting 
distinct segments of coding regions of NEK10 and CHIP were 
purchased from IDT and Life technologies.  
The siRNA sequence (IDT) targeting the 3’-UTR (untranslated 
region) of human NEK10: sense sequence: 
CCACAAGACAUUAGUAAA UUUACTT antisense sequence: 
CGGGUGUUCUGUAAUC AUUUAAAUGAA or human 
CHIP sense sequence: UUACACCAACCGGGCCUUtt; 
antisense sequence: CAAGGCCC GGUUGGUGUAAta. 
siRNAs were transiently transfected using Lipofectamine 2000 
(Invitrogen) at a final concentration of 100 pmol/ml of 
culture medium.  
 
3.3 Antibodies and chemicals. Polyclonal antibodies directed 
against PCM1 were purchased from ABCAM and Cell 
Signaling and used at working 1:1000; rabbit polyclonal 
antibodies directed against phosphoPKA was purchased from 
Cell Signaling and used at working dilution of 1:1000; 
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monoclonal antibodies directed against RIIβ was purchased 
from BD Transduction and used at working 1:2000; 
haemagglutinin epitope (HA) was purchased from Covance and 
used at working diluition of 1:1000; monoclonal antibodies 
directed against flag and myc epitope used at working diluition 
1:3000 were purchased from Sigma; polyclonal antibodies 
directed against acetylated alpha tubulin was purchased from 
ABCAM. Forskolin was purchased from Sigma.  
 
3.4 Immunoprecipitation and pull down assay. Cells were 
washed twice with phosphate-buffered saline and lysed in a 
buffer (50mM TRIS–hydrogen chloride, pH 7.4, 150mM 
sodium chloride, 5mM magnesium chloride, 5mM dithiothreitol, 
1mM ethylene diamine tetraacetic acid, 1% Triton X-
100,containing aprotinin (5 g/ml), leupeptin (10 g/ml), 
pepstatin (2 g/ml), Na3VO4 and 1mM phenylmethylsulfonyl 
fluoride and protease inhibitors. The lysates were cleared by 
centrifugation at 15,000 g for 15 min. Cell lysates (2 mg) were 
immunoprecipitated in rotation at 4 °C overnight with the 
indicated antibodies. Pellets were washed four times in lysis 
buffer and eluted in Laemly buffer.An aliquot of whole cell 
lysates (WCE) (100 g) or immunoprecipitates were resolved on 
sodium dodecyl sulfate polyacrylamide gel and transferred on 
nitrocellulose membrane (Biorad, Milan, Italy) for 3 h. Filters 
were blocked for 1 h at room temperature in Tween-20 
Phosphate buffer saline (TPBS) (PBS- Sigma, 0, 1% Tween 20, 
pH 7.4) containing 5% non-fat dry milk. Blots were then 
incubated O/N with primary antibody. Blots were washed three 
times with TPBS buffer and then incubated for 1 h with 
secondary antibody (peroxidase-coupled anti rabbit (GE-
Healthcare) in TPBS. Reactive signals were revealed by 
enhanced ECL Western Blotting analysis system (Roche).  
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GST-fusions were expressed and purified from BL21 (DE3) 
pLysS cells. GST hybrid proteins immobilized on glutathione 
beads were incubated for 3 hr with cell lysates from HEK293 
cells transiently expressing flag-NEK10 constructs in lysis 
buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.5, 5mM MgCl2, 
5mM DDT, 1 mM EDTA, 1% triton X-100) in rotation at 4 °C 
for 4 hours. Pellets were washed four times in lysis buffer 
supplemented with NaCl (1 M final concentration) and eluted in 
Laemmli buffer. Eluted samples were size-fractionated on SDS-
PAGE and immunoblotted. 
 
3.5 PKA phosphorylation assay. Cells transfected with either 
wild type NEK10-flag or with NEK10-flag mutants (T223A-
Flag and T812A-Flag) were left untreated or stimulated with 
FSK (15min). NEK10 was immunopurified with anti-flag 
antibodies. The precipitates were immunoblotted with anti-flag 
and with anti-phospho-(K/R)(K/R)X(S*/T*) specific antibodies. 
The quantification is shown from n=4 independent experiments 
(± SEM). 
 
3.6 Immunofluorescence and confocal analysis. For 
immunofluorescence studies, HEK293 cells transiently 
transfected with the expression vectors were plated on poly-L-
lysine (10µg/ml) coated glass coverslips. Cells were fixed with 
Paraformaldehyde for 20 minutes. After three washes, cells were 
immunostained with polyclonal antibodies directed against 
PCM1 was purchased from ABCAM, with polyclonal directed 
against NEK10 and used at working diluitions of 1:100; 
monoclonal antibodies directed against RIIβ was purchased 
from BD Transduction and used at working diluition of 1:400, 
monoclonal antibodies directed against Flag epitope used at 
working dilution of 1:400; polyclonal antibodies directed against  
acetylated alpha tubulin was purchased from ABCAM and used 
at working dilution of 1:100. High-resolution images were 
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acquired with a Zeiss LSM 880 confocal microscope equipped 
with Airyscan superresolution imaging module, using a 
63×/1.40 NA Plan-Apochromat Oil DIC M27 objective lens 
(Zeiss MicroImaging, Jena, Germany)  
 
3.7 Statistics Data were analyzed using analysis of variance 
(ANOVA) for each region and post hoc repeated-measure 
comparisons (Least Significant Difference (LSD) test). 
Rejection level was set at P < 0.05. 
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4 RESULTS 
 
4.1 NEK10, RIIβ and PCM1 form a macromolecular complex 
 
A proteomic analysis using full-length RIIβ as bait revealed that 
the pericentriolar matrix protein 1 (PCM1) and the Nima-related 
Kinase 10 (NEK10) form a complex with PKA. To verify the 
interaction between these proteins, I performed a co-
immunoprecipitation assay (Fig. 7a). HEK293 cells were 
transfected for 24 hours with NEK10-flag vector. Lysates were 
immunoprecipitated with anti-RIIβ or non-immune IgG 
antibodies and the precipitates were immunoblotted with anti-
PCM1, anti-flag and anti-RIIβ antibodies. The data in figure 7a 
show the existence of a trimeric complex composed of PKA, 
NEK10 and PCM1.I confirmed this interaction using an in vitro 
GST-pull down assays with the recombinant proteins (Fig. 7b). I 
transfected HEK293 cells with NEK10-flag vector and 
incubated the lysates with purified GST or GST–RIIβ fusion. 
The precipitates were immunoblotted with anti-PCM1, anti-flag 
and anti-RIIβ antibodies. Figure 7b confirmed the interaction 
between PCM1, NEK10 and RIIβ proteins. 
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Fig.7 (a) HEK293 cells were transiently transfected with NEK10-flag vector, 
lysates were immunoprecipitated with anti-RIIβ or non-immune IgG 
antibodies and immunoblotted with anti-PCM1, anti-RIIβ and anti-flag 
antibodies. (b) HEK293 cells were transiently transfected with NEK10-flag 
vector; lysates and immunoprecipitates were subjected to pull down assays 
with purified GST or GST–RIIβ fusion. The precipitates and lysates were 
immunoblotted with anti-PCM1, anti-flag and anti-GST antibodies.
 
a b 
 29 
 
4.2  Endogenous PCM1, NEK10 and RIIβ colocalize in 
Human Embryonic Kidney 293 cells 
 
To demonstrate that PCM1, NEK10 and RIIβ are located within 
the same compartment, I analyzed the localization of the three 
proteins in HEK293 cells. For this experiment, I performed a 
triple immunofluorescence assay using anti-PCM1, anti-NEK10 
and anti-RIIβ antibodies (Fig. 8). As shown in the figure, 
immunostaining analysis revealed that the three signals partially 
colocalize at pericentriolar region, supporting the concept that a 
fraction of PCM1, NEK10 and RIIβ proteins is restricted within 
the same intracellular compartment. 
 
 
Fig.8 PCM1, NEK10 AND RIIβ colocalize in Human Embryonic Kidney 
cells. HEK293 were subjected to immunofluorescence assay with goat 
polyclonal anti-NEK10, rabbit polyclonal anti-PCM1 and mouse monoclonal 
anti-RIIβ antibodies. The merge composite of the signals shows co-
localization of PCM1, NEK10 and RIIβ at pericentriolar region. Scale bar: 5 
µm. 
 
 
 
4.3  NEK10 is required for ciliogenesis 
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NEK10 belongs to Nima related kinase family (NEKs) whose 
members take part to different events underlying to cell cycle 
progression, centrosome and microtubules formation, and 
mammalian ciliogenesis. Since these structures are intimately 
involved both in the assembly of the mitotic spindle and in 
ciliogenesis
69
, we asked if NEK10 also contributes to the 
primary cilium assembly. Firstly, I demonstrated that NEK10 
localizes at primary cilium. For this experiment, I deprived 
HEK293 cells from serum for 36 hours to induce primary cilium 
formation. Then, I performed a double immunofluorescence 
assay using anti-NEK10 and anti-acetylated tubulin antibodies. 
Acetylated tubulin is a modified variant of tubulin that 
selectively accumulates along the cilium. The immunostaining 
analysis shows that a significant amount of NEK10 protein 
localizes at the base and along the axoneme of primary cilium 
(Fig. 9) 
 
Fig.9 NEK10 localizes at primary cilium. HEK293 cells were serum-
deprived for 36 hours and then immunostained for NEK10 (red) and 
acetylated tubulin (green) antibodies. The signal was analyzed by confocal 
microscope equipped with Airyscan super resolution imaging module. A 
merge composite 2D and 3D of the signals shown that NEK10 localized 
along axoneme of primary cilium. 
 
 
Once demonstrated the localization of NEK10 in human cells 
along the primary cilium, I verified the role of NEK10 during 
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primary cilium assembly. To this aim, I transfected transiently 
HEK293 cells with siRNA targeting endogenous NEK10 and 
deprived cells from serum for 36 hours. The data shows that, in 
control (siRNAc) cells, serum deprivation significantly 
increased the number of primary cilia. In contrast, genetic 
knock-down of NEK10 drastically reduced the number of 
ciliated cells. Re-expression of NEK10 reversed the effects of 
NEK10 silencing, indicating that NEK10 is, indeed, a 
biologically relevant player of ciliogenesis. (Fig 10.a). 
Moreover, I repeated the experiment using the kinase-dead 
mutant of NEK10 (NEK10-KD) carrying an inactivating 
mutation within the catalytic domain (K548R). As shown in the 
figure, the NEK10 mutant critically reduced the number of 
ciliated cells. In the Fig 10.b are showed the levels of NEK10 in 
siRNA transfected cells monitored by immunostaining. 
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Fig.10 (a) NEK10 is required for ciliogenesis. HEK293 cells were 
transiently transfected with control (siCNT) or with siRNAs targeting 
NEK10 (siNEK10), serum deprived for 36 hours, fixed and immunostained 
with anti-acetylated alpha tubulin and with anti-Flag antibodies (for NEK10-
flag). Where indicated, NEK10-flag vector (either wild type or kinase dead, 
KD) was included in the siRNAs transfection mixture. Arrows indicate the 
localization of the cilium in cells expressing flag-tagged NEK10. Cumulative 
data from three independent experiments are shown (lower right panel). (b) 
The levels of NEK10 in siRNA‐transfected cells were monitored by 
immunostaining.  
 
 
 
 
 
 
a 
b 
b 
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4.4 PKA regulates the stability of primary cilium 
 
The experiments above indicate that NEK10, PCM1 and PKA 
form a stable complex at pericentriolar region. A fraction of 
NEK10 localizes at- and regulates primary cilium formation. 
Previous work demonstrated that a pool of PKA is localized at 
the base of primary cilium through interaction with an as yet 
identified scaffold protein
62
. Localization of PKA at cilium is 
required for cilium formation. However, the impact of PKA 
activation cilium stability was largely unknown. Accordingly, I 
investigated the role of PKA activation on cilium stability. 
HEK293 cells where serum deprived for 36 hours and then 
stimulated with forskolin (FSK), a diterpene that activates 
adenylate cyclase (AC), or with isoproterenol (ISO), a beta-
adrenergic receptor (bAR) agonist. Cells were subjected to 
immunostaining analysis using anti-acetylated tubulin antibody. 
As shown in Fig.11, treatment with FSK or Isoprotenerol 
strongly decreased the number of ciliated cells. These data 
suggested that activation of cAMP signaling critically impacts 
on primary cilium stability.  
 
 
 
 
 
 
+ ISO 5m 
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Fig.11 cAMP induced resorption of primary cilium.  HEK293 cells were 
serum deprived for 36h and then left untreated (CNT) or stimulated with 
isoproterenol (Iso) or forskolin (FSK) for 3 hours. The same cells were 
immunostained with anti-acetylated tubulin and Draq5. Cumulative data from 
five independent experiments are shown (lower right panel) 
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4.5 PKA phosphorylation primes NEK10 for proteolysis via 
UPS 
 
Our data indicate that NEK10 is required for ciliogenesis, while 
PKA activation induces cilium resorption. Since NEK10 and 
PKA are present within the same multimeric complex assembled 
by PCM1, I tested if/how PKA activation regulates NEK10 
levels. To this aim, I monitored the levels of NEK10 in HEK293 
cells after the treatment with FSK for 1 hour. The data shown in 
Fig.12 revealed that the activation of PKA by FSK caused a 
severe decrease of NEK10 levels. The effects of forskolin on 
NEK10 levels were abrogated by pre-treating the cells with the 
proteasome inhibitor MG132. 
The data indicate that, in response to cAMP stimulation, NEK10 
undergoes to proteasomal degradation.  
 
 
 
  
 
 
 
 
Fig.12 PKA stimulation induces proteolysis of NEK10 by the 
proteasome. HEK293 cells were transiently transfected with NEK10-flag.  
After 24 hours, cells were harvested and treated with forskolin (40µM). 
Where indicated, cells were pretreated with MG132 (20µM/3 hours). Lysates 
were immunoblotted with anti-flag or anti-tubulin antibodies. 
 
 
 
MG132 - 
FSK  - 
- 
+ 
+ 
- 
+ 
+ 
NEK10-flag + + + + - 
- 
- 
130- 
  55- 
flag 
 tubulin 
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The data above indicate that, in response to cAMP stimulation, 
NEK10 undergoes proteasomal degradation. We assume that 
PKA phosphorylation primes NEK10 for proteolysis. Primary 
sequence analysis of NEK10 predicts two conserved PKA 
phosphorylation sites (T223 and T812) (Fig.13).  
 
 
 
 
 
 
 
 
Fig.13 Schematic diagram showing the protein sequence of human NEK10 
and the putative PKA consensus sites (thr223 and thr812). 
 
 
 
 
To ask if phosphorylation of one or both of these sites renders 
NEK10 susceptible to proteolysis, we generated mutant forms of 
NEK10 using a site-directed mutagenesis to substitute either 
T223 or T812 with alanine. We tested our hypothesis by 
analyzing the phosphorylation status of affinity-isolated NEK10 
with a PKA substrate antibody. In contrast to phosphorylation of 
the wild type and T223A NEK10 mutant, the substitution of 
T812A abolished both basal and FSK-induced NEK10 
phosphorylation (Fig.14). 
 
 
 
 
T223A T812A 
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Fig.14 PKA phosphorylates NEK10 at threonine 812. HEK293 cells were 
transfected with either wild type NEK10-flag or with NEK10-flag mutants 
(T223A-Flag and T812A-Flag) and were left untreated or stimulated with 
FSK (40µM715 min). NEK10 was immunopurified with anti-flag antibodies 
and the precipitates were immunoblotted with anti-flag and anti-phospho-
(K/R) (K/R) X(S*/T*) specific antibodies. 
 
 
 
  
Next, we asked if this phosphorylation by PKA is required to 
induce NEK10 proteolysis. To verify this hypothesis, I 
evaluated the levels of NEK10 in cells transfected either with 
NEK10 wild type or with T812A mutant vectors. Both cell lines 
were stimulated with FSK (Fig.15a) or Isoproterenol (Fig.15b) 
for 30 and 60 minutes. The figures show that the phospho 
mutant (T812A), not sensible to phosphorylation by PKA, is not 
degradated by FSK and ISO compared to wild type protein.  
 
Ubiquitination is required for proteasomal degradation of a 
variety of cellular substrates
80
. Accordingly, I asked if cAMP 
induces ubiquitination of NEK10. To test this hypothesis, I 
performed ubiquitination assays in HEK293 cells transfected 
either with hemagglutinin (HA)-tagged ubiquitin and NEK10 
(wild type or T812A mutant) and treated with FSK for 60 
minutes. The lysates were immunoprecipitates with anti-flag 
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antibody and the precipitates were immunoblotted with anti-HA 
antibody. Fig.15c shows that FSK induces the accumulation of 
poly-ubiquitinated forms of NEK10, whereas this poly-
ubiquitination was abrogated by the T812A mutation. These 
experiments confirmed that phosphorylation by PKA is 
necessary to prime proteolysis of NEK10 via UPS. 
 
 
 
 
 
Fig.15 (a) Phosphorylation by PKA drives proteolysis of NEK10. (a-b) 
Cells transfected with either wild type NEK10-flag or with T812A-flag 
mutant were left untreated or stimulated with forskolin (a) or isoproterenol 
(b) for 30-60 min. Total cell lysates were immunoblotted with anti-flag and 
anti-tubulin antibodies. (c) Cells were transiently co-transfected with 
NEK10-flag construct (either wild type or T812A mutant) and HA-ubiquitin. 
Lysates were subjected to immunoprecipitation with anti-flag and 
immunoblotted with anti-HA and anti-flag antibodies. 
 
a b 
c 
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Next, I tested if NEK10 phosphorylation was required for 
primary cilium disassembly induced by the cAMP cascade. 
Cells were transiently transfected with NEK10 (either wild type 
or the NEK10-T812A mutant), serum-deprived for two days and 
then treated with FSK. As shown in Fig.16, the T812A mutation 
prevented FSK-induced cilia disassembly, supporting the 
concept that PKA phosphorylation of T812 primes NEK10 for 
proteolysis, which results in cilia disassembly. 
 
 
Fig.16. Phosphorylation of NEK10 by PKA induced cilia resorption. 
HEK293 cells were transfected with either wild type NEK10-flag or with 
T812A-flag mutant. After transfection, cells were serum deprived for 36h and 
left untreated or stimulated with FSK (40µM/3 hours). Cells were subjected 
to a double immunofluorescence for flag (red) and acetylated tubulin (green). 
Cumulative data from three independent experiments are shown on right 
panel.  
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4.6  CHIP is the NEK10 E3 ubiquitin ligase 
 
Since NEK10 is efficiently ubiquitinated under cAMP 
stimulation, it was necessary to identify the E3 ligase 
responsible for this ubiquitination. A proteomic analysis 
identified several PKA partners; one of this is the E3 ubiquitin 
ligase C-terminus of HSP70 interacting protein (CHIP) known 
as STUB1. CHIP is a chaperone-associated E3ligase involved in 
the ubiquitination and degradation of HSP70-bound substrates 
and contains a tetra-tricopeptide (TPR) motif tandem repeats 
that mediates interaction with HSP70.  First, I verified the 
interaction between the two proteins. I performed a co-
immunoprecipitation assay using lysates from cells transfected 
with NEK10-flag, HSP70-V5 and CHIP-Myc vectors. The 
lysates were immunoprecipitated with anti-myc antibody and 
precipitates were immunoblotted with anti-flag, anti-V5 and 
anti-myc antibodies. As shown in Fig.17a the three proteins 
form a stable complex in cell lysate. 
Then, I tested if the binding between NEK10, CHIP and HSP70 
was regulated by cAMP. To this aim, I performed a co-
immunoprecipitation assay using lysates from cells transfected 
either with NEK10 wild type or with NEK-T812A mutant. Cells 
were induced with FSK for 30 minutes; the lysates were 
immunoprecipitated with anti-myc antibody and immunoblotted 
with anti-flag, anti-V5 and anti-myc antibodies. The Fig.17b-c 
shows that the binding between NEK10, HSP70 and CHIP 
increases after the treatment with FSK, in contrast, the T812A 
mutation significantly decreases NEK10 binding to CHIP. 
 
 
 
 
 41 
 
 
 
 
 
Fig.17 (a) cAMP-induced binding of CHIP to NEK10. HEK293 cells were 
transiently co-transfected with NEK10-flag, HSP70-V5 and CHIP-myc 
vectors. To prevent NEK10 degradation by CHIP, cells were treated with 
MG132 (20µM/8hours) before harvesting. Lysates were immunoprecipitated 
with anti-flag or with control IgG. The precipitates and lysates were 
immunoblotted with the indicated antibodies. (b) Cells were co-transfected 
with NEK10-flag vectors (either wild type or T812A mutant), HSP70-V5 and 
CHIP-myc, serum deprived for 24 hours and then left untreated or stimulated 
with FSK (40µM/30 min). Lysates were immunoprecipitated with anti-flag 
antibody and were immunoblotted with the indicated antibodies. (c) 
Cumulative data of three independent experiments shown in b. 
 
 
 
 
 
 
 
 
b 
a 
b c 
a 
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We then asked if CHIP degrades NEK10 in the absence of 
MG132. In the Fig. 17d I co-transfected cells with NEK10-flag 
and CHIP-myc vectors, alternately with wild type or with 
catalytically inactive mutant (K30A) of CHIP that does not bind 
HSP70. The lysates were immunoblotted with anti flag, myc and 
tubulin antibodies. The figure shows that  in presence of CHIP 
wild type there is a decrease of NEK10 levels whereas CHIP-
K30A mutant  in not able to degradate NEK10. 
In the Fig17.e I performed an ubiquitination assay using cells 
transfected with control siRNAs or siRNAs targeting 
endogenous CHIP. After transfection, cells were left untreated 
or stimulated with Isoprotenerol for 1 hour. The figure shows 
that in basal condition there is an accumulation of poly-
ubiquitinated form of NEK10 ISO dependent, by the contrast, 
the genetic knock-down of endogenous CHIP prevented ISO-
induced NEK10 polyubiquitination. These findings supported 
the idea that PKA controls NEK10 stability through CHIP. 
 
 
Fig.17 CHIP ubiquitylates NEK10. (d) Lysates from cells co-transfected 
with NEK10-flag and CHIP (either wild type or K30A mutant) were 
immunoblotted with the indicated antibodies (e) Cells co-transfected with 
HA-ubiquitin, NEK10-flag and siRNAs (either control siRNA or siCHIP) 
were serum-deprived overnight and stimulated with isoproterenol for 1 hour. 
Lysates were subjected to immunoprecipitation with anti-flag antibody. 
Ubiquitinated NEK10 was revealed by immunoblot with anti-HA antibodies. 
d e 
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Once determined that cAMP primes proteolysis of NEK10 
through the interaction with CHIP, we verified if CHIP mediates 
the effects of cAMP on cilia stability. To this aim, I transfected 
HEK293 cells with control siRNAs or siRNAs targeting 
endogenous CHIP. Twenty hours after the transfection I 
deprived the cells from serum for 36 hours and treated them 
with FSK for 3 hours. Cells were subjected to 
immunofluorescence assay with anti-acetylated tubulin 
antibody. As shown in the figure (Fig 17f), down regulation of 
endogenous CHIP prevented cilia resorption induced by FSK 
treatment.  
 
Fig.17 CHIP ubiquitylates NEK10 and mediates cAMP effects on 
primary cilium stability  (f) Cells were transiently transfected with control 
or with siRNAs targeting CHIP, serum-deprived for 36h and then left 
untreated or stimulated with FSK (40µM) for 3 hours. Primary cilia were 
visualized by immunostaining with acetylated tubulin antibody whereas 
nuclei with Draq5. Cumulative data from five independent experiments are 
shown in the graph near the figure.  
 
 
 
 
 
 
f 
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4.7 Dysregulation of CHIP affects cilia in SCAR16 disease 
 
Biallelic STUB1 mutations resulting in aberrant CHIP have been 
identified in patients with clinical features of autosomal 
recessive spinocerebellar ataxia-16 (SCAR16). This is a rare 
genetic syndrome characterized by truncal and limb ataxia 
resulting in gait instability, mild peripheral sensory neuropathy, 
and cognitive defects. Hypogonadism can also be present in 
these patients (Gordon Holmes syndrome, GHS), consistent with 
signaling defects and altered responses to hypothalamic 
hormones. Mice lacking STUB1/CHIP gene show a phenotype 
that recapitulates most of the SCAR16 features
81
. Accordingly, 
we determined if CHIP mutations affect primary cilia. We 
analyzed ciliogenesis in primary fibroblasts isolated from 
cutaneous biopsies of SCAR16 patients or from healthy 
volunteers. Fig.18 shows that FSK treatment in normal 
fibroblasts promoted resorption of cilia. In contrast, no major 
effects of FSK stimulation on cilia were evident in SCAR16 
fibroblasts. Interestingly, genetic silencing of NEK10 in 
SCAR16 fibroblasts markedly reduced the number of ciliated 
cells, even in the absence of FSK, further supporting a role of 
the CHIP-NEK10 axis in control of cilium stability. 
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Fig.18  CHIP, NEK10 and cilia in SCAR16 fibroblasts. Skin fibroblasts 
from healthy volunteers (BJ) and SCAR16 patients (AX71) were serum 
deprived for 48h and treated with FSK (80 µM/6h). Cells were fixed and 
stained for acetylated tubulin and Draq5. Where indicated, AX71 cells were 
transiently transfected with control siRNA or with siRNA targeting 
endogenous NEK10, before stimulation. Cumulative data from 4 independent 
experiments are shown.  
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5 DISCUSSION AND CONCLUSION 
 
Primary cilia are considered very important organelles that 
emanate from cell surface and are able to detect external signals 
and reintroduce them into cells. Primary cilia are present on the 
apical surface of the majority of cells in the human body and the 
structure that promotes the assembly of primary cilium is the 
centrosome, the principal microtubule organizing center 
(MTOC) in animal cells. The cilium is composed by axoneme 
and the basal body
53
.  
The primary cilium is a compartmentalized complex for signal 
integration and propagation relevant for many developmental 
processes. In dividing cells, the transition between centrosome 
and primary cilium is functionally linked. In mitotic interphase, 
centrosomes organize the cytoplasmic microtubule network, 
whereas in mitosis they regulate mitotic spindle dynamics and 
cytokinesis. In postmitotic cells, the centrosome migrates to the 
cell surface, and one of the centrioles differentiates into a basal 
body from which microtubules nucleate to form a primary 
cilium. In normal proliferating cells, the cilium can be 
transiently observed in G1 phase, disappearing when the cell 
enters the cell cycle
82
. A significant fraction of PKA is localized 
at the base of cilium through interaction with AKAPs, 
controlling essential aspects of ciliogenesis and the Hedgehog 
(Hh) pathway. However, the impact of PKA activation on the 
turnover of ciliary proteins and its role in primary cilium 
stability were largely unknown. 
As mentioned above, there is a  thigh connection between cAMP 
cascade and UPS system and derangements in these mechanisms 
are linked to arise several neurodegenerative and proliferative 
disorders.  
 In the thesis, I reported the identification of the serine/threonine 
kinase NEK10 as a novel positive regulator of ciliogenesis. 
NEK10 is member of the Nima-related kinases activated at 
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G2/M transition and its activity is required for proper cell cycle 
progression. I demonstrated the existence of a macromolecular 
complex in which NEK10 is localized at the primary cilium 
through the interaction with PKA and PCM1, a pericentriolar 
scaffold protein involved in different aspects of microtubule 
dynamics, cell division and ciliogenesis. I found that NEK10 
protein stability is a critical determinant for the 
assembly/disassembly of cilium and it is mediated by the GPCR 
signaling. By a combinatorial approach of biochemistry, cell 
biology and molecular genetics, I demonstrate the presence of a 
trimeric complex composed by NEK10, PCM1 and regulatory 
subunit of PKA (RIIβ) at pericentriolar region of mammalian 
cells. In particular, I found that NEK10 localizes at the base and 
along the axoneme of primary cilium.  NEK10 down regulation 
severely affected the assembly of primary cilium. 
I also analyzed the intersection between GPCR signaling and 
primary cilium. I found that NEK10 is a novel direct target of 
PKA. Phosphorylation of NEK10 by PKA at Thr812 primes 
NEK10 to ubiquitination and proteolysis. Disappearance of 
NEK10 promotes cilia resorption. A proteomic analysis allowed 
the identification of CHIP as the E3 ubiquitin ligase that binds 
to- and ubiquitylates NEK10, causing NEK10 proteolysis 
through the UPS and cilia resorption. Removal of CHIP 
prevented cAMP effects on cilium resorption. These findings 
point to CHIP as a novel regulator of protein turnover at ciliary 
sites that efficiently couples GPCR signaling to cilia dynamics. 
This mode of regulation was further supported by evidence that 
germline inactivating mutations of CHIP that cause SCAR16 
disease prevented cAMP-induced disassembly of cilia. 
Altogether, the findings reported in my thesis elucidate the 
mechanism(s) underlying cilia resorption during GPCR 
stimulation, both in healthy and disease conditions. They also 
provide mechanistic insights into how cAMP controls cell 
growth. It is well established that the cAMP cascade regulates 
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growth and differentiation of a wide variety of cell types. PKA 
activation can either induce or inhibit cell growth, depending on 
cell type or metabolic conditions
83
. In growth-arrested endocrine 
cells, the cAMP-PKA pathway promotes the transition from G0 
to G1 phase, allowing the cells to progress through the cell 
cycle
84
. The transition from quiescent to proliferative state 
requires disassembly of the primary cilium. 
Several targets of PKA have been identified and causally linked 
to induction of cell growth. However, if and how PKA 
activation modulates the activity of proteins controlling cilia 
stability in starved cells was largely unexplored. These findings 
help to define the relevance of PKA pathway in cilia resorption 
in the course of hormone stimulation. We show that PKA 
activation by cAMP agonists targets NEK10 for proteolysis 
through the UPS. The cAMP cascade induces cilia disassembly 
and promotes entry into the cell cycle by removing the NEK10 
pro-ciliogenic kinase. NEK10 thus represents a nodal point in 
the ciliary compartment where cAMP signaling and the UPS 
converge and integrate to control essential aspects of cilia 
dynamics and, most likely, cell growth. Mutations affecting any 
component of this proteolyitc machinery may alter the 
sensitivity of the cells to hormones or growth factors, 
profoundly impacting on cell growth and vertebrate 
development. 
Although the results of my thesis enhance the role of cAMP  
into disassembly of primary cilium, there are some points that 
need to be addressed. It is important to understand whether cilia 
resorption induced by cAMP has a physiologically relevant 
implications for cell biology. Previous work revealed that 
activation of cAMP pathway promotes ciliogenesis.
85, 86
. 
This apparent discrepancy could not be ascribed to the different 
cell models used, since we confirmed that in serum 
supplemented, confluent cells cAMP stimulation had no major 
impact on cilum stability (data not shown). These findings 
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suggest that cAMP pathway may have a dual effect on primary 
cilia depending on how growth arrest is achieved. In the 
presence of serum, cAMP contributes to primary ciliogenesis 
induced by cell confluency, while under serum starvation the 
same messenger promotes cilium disassembly. 
Finally, the findings reported in my thesis indicate that NEK10 
is a new ciliary protein that in concert with other centriolar  
proteins plays a major role in the regulation of 
assembly/disassembly of primary cilium.  
My next goal is the identification and the molecular 
characterization of the relevant NEK10 substrates involved in 
mammalian ciliogenesis. Derangement of this NEK10-regulated 
signaling circuitry may underpin to genetic and proliferative 
disorders human disorders.  
 In conclusion, I have identified a PCM1-centered multimeric 
complex that functionally links second messenger signaling 
(cAMP), kinase activities (PKA, NEK10) and the UPS (CHIP) 
to cilia dynamics. This mechanism explains how 
compartmentalized signaling networks regulate cilia formation 
in both physiological and pathological conditions. 
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Figure 19. Molecular mechanism model. Under resting conditions, PKA 
holoenzyme form a stable complex with PCM1 and NEK10, promoting 
ciliogenesis. Elevation of intracellular cAMP levels by ligand (L) stimulation 
of the adenylate cyclase (AC) efficiently activates PKA which 
phosphorylates NEK10. Phosphorylation primes ubiquitin-dependent 
proteolysis of NEK10 by E3 ligase CHIP. The decrease of NEK10 levels 
promotes the resorption of primary cilium.  
  
 51 
 
6 APPENDICES 
AC Adenylyl cyclase 
GPCR G protein coupled receptor 
PKA Protein kinase A 
PDE Phosphodiesterase 
UPS Ubiquitin Proteasome System 
CHIP C-terminus of HSC70 interacting protein 
FSK Forskolin 
ISO Isoprotenerol 
cAMP cyclic AMP 
EPAC RAP exchange proteins 
cNGC cAMP gated ion channels 
AKAP A-Kinase-Anchor-Proteins 
TPR tetratricopeptide repeats domain 
SCAR16 spinocerebellar ataxia autosomal recessive 16 
PCM1 pericentriolar matrix protein 1 
NEK10 Nima-related Kinase 10 
RIIβ 51egulatory subunit of PKA 
Hh Hedgehog 
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